Skip to main content
CXW
NYSE Real Estate & Construction

CoreCivic Q3 EPS $14.49 on $1.8B Facility Gain; Board Adds $500M to Buyback

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Security & Protection Stocks · Industrial
Sentiment info
Positive
Importance info
8
Price
$30.2
Mkt Cap
$3.018B
52W Low
$15.735
52W High
$36.55
52W Position info
92% above low
Off High info
17% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

CXW sits 92% above its 52-week low of $15.735.

Summary

CoreCivic reported Q3 2026 net income of $1.34 billion ($14.49 per diluted share) on a $1.77 billion gain from selling four facilities to DHS, while Adjusted EPS doubled to $0.49. The board added $500 million to the share repurchase program, bringing total authorization to $1.7 billion with about $755.8 million remaining.


Key Events · Earnings and Guidance · CXW

  • Q3 Results Boosted by Facility Sales

    Total revenue rose 28.2% to $744.1 million and net income reached $1,344.1 million, or $14.49 per diluted share, driven by a $1,770.7 million net gain on the sale of four detention facilities to DHS for $2.2 billion gross.

  • Operating Earnings Improve Sharply

    Excluding the gain and other special items, Adjusted Diluted EPS doubled to $0.49 from $0.24 and Adjusted EBITDA rose 32.6% to $117.8 million, helped by occupancy of 84.0% versus 76.7% a year earlier.

  • Buyback Authorization Raised by $500M

    The board authorized an additional $500.0 million on November 3, 2026, lifting the program from $1.2 billion to $1.7 billion; approximately $755.8 million remains available before any further ASR settlement.

  • Balance Sheet Deleveraged After Asset Sale

    CoreCivic applied $1.6 billion of after-tax proceeds to repay over $700 million of debt and fund a $500 million accelerated share repurchase, reducing net debt to Adjusted EBITDA to (0.1)x from 2.5x.


Analysis · CXW · Real Estate & Construction

CoreCivic's third quarter was dominated by the $2.2 billion sale of four detention facilities to the Department of Homeland Security, which produced a $1.77 billion net gain and turned reported net income into $1.34 billion, or $14.49 per diluted share. Strip that out and the operating business still improved: Adjusted Diluted EPS rose 104% to $0.49 and Adjusted EBITDA rose 32.6% to $117.8 million on higher ICE occupancy and the Clinical Solutions Pharmacy acquisition. The company used $1.6 billion of after-tax proceeds to repay over $700 million of debt and fund a $500 million accelerated share repurchase, cutting net debt to Adjusted EBITDA to (0.1)x from 2.5x. The board then added another $500 million to the buyback on November 3, leaving roughly $755.8 million available. Guidance was mixed: Adjusted Diluted EPS and Adjusted EBITDA ranges were raised, but GAAP net income was trimmed, largely reflecting the facility-sale gain already booked.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CXW was trading at $30.20 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $3B. The 52-week trading range was $15.74 to $36.55. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CXW - Latest Insights

CXW
Nov 05, 2026, 12:03 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $29.37
Real-time Price: $29.93 info
Change: +$0.560 (+2%) info
Market Cap: $2.589B info
CXW
Nov 04, 2026, 4:47 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $30.49
Real-time Price: $29.93 info
Change: -$0.560 (-2%) info
Market Cap: $2.589B info
CXW
Nov 04, 2026, 4:15 PM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $30.49
Real-time Price: $29.93 info
Change: -$0.560 (-2%) info
Market Cap: $2.589B info
CXW
Sep 25, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $32.13
Real-time Price: $29.93 info
Change: -$2.20 (-7%) info
Market Cap: $2.589B info
CXW
Sep 25, 2026, 8:21 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $33.18
Real-time Price: $29.93 info
Change: -$3.25 (-10%) info
Market Cap: $2.589B info